Jenny Lee-Gilmore had trouble staying awake in school, vivid sleep hallucinations and would wake up six to 10 times per night ...

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the publication of combined findings from a social media ...

ZURICH, SWITZERLAND / ACCESSWIRE / December 11, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the ...

Dive into the secrets of sleep disorders, their hidden toll on health, and the groundbreaking treatments reshaping America's ...

Perceived social support was significantly lower among individuals with idiopathic hypersomnia or narcolepsy type 2 compared with narcolepsy type 1.

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-commerce, Drug Stores and Others) & Region for 2024 to ...

“Many people are never seen by a sleep specialist, who is one of the few physicians trained to recognize the symptoms.” A large percentage of people with narcolepsy have cataplexy as ...

Narcolepsy is a nervous system disorder that involves your brain. You struggle to manage sleep patterns and stay awake. No matter how much rest you got the night before, an intense urge to sleep ...

Axsome's AXS-12 reduces narcolepsy symptoms, positioning the company for success. Find out why AXSM stock is a buy with ...

The primary outcome measure was the change from baseline in laryngeal dystonia symptom severity 40 minutes after sodium ...

017). Topline results were announced from a phase 3 trial evaluating AXS-12 (reboxetine) in patients with narcolepsy. AXS-12 is an investigational highly selective potent norepinephrine reuptake ...